Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: RHS90QRF9E

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor protein-tyrosine kinase erbB-2 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 3 D001943 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Adenocarcinoma 2 D000230 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594568
FDA SRS RHS90QRF9E